Global Narcolepsy Drugs Market to Reach US$ 6.2 Billion by 2032, Accelerated by Increasing Prevalence of Narcolepsy

June 23, 2023 | Healthcare

As per the latest report by IMARC Group, titled "Narcolepsy Drugs Market Report by Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy), Disease Type (Daytime Extreme Sleepiness, Cataplexia, and Others), Therapeutic Type (Sodium Oxybate, Central Nervous System Stimulants, Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitor, and Others), and Region 2024-2032," the global narcolepsy drugs market size reached US$ 3.3 Billion in 2023. Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness and sudden attacks of sleep. The advancements in medical science have led to the development of narcolepsy drugs that offer relief to those afflicted by this condition. These drugs are typically comprised of specific components that target the underlying causes of narcolepsy and help regulate sleep-wake cycles. Narcolepsy drugs primarily affect neurotransmitters in the brain, particularly those involved in regulating wakefulness and sleep. One common component found in these medications is Modafinil, a wake-promoting agent that stimulates the release of histamine, norepinephrine, dopamine, and other neurotransmitters. By increasing these neurotransmitters' levels, Modafinil helps promote wakefulness and reduce excessive daytime sleepiness in individuals with narcolepsy. The advantages of these drugs extend beyond alleviating excessive sleepiness, such as enhancing cognitive function, improving attention, and reducing the frequency of cataplexy attacks. Currently, different types of product variants are available to cater to specific needs and symptom severity, including methylphenidate and amphetamines, serotonin reuptake inhibitors (SSRIs), and norepinephrine reuptake inhibitors (NRIs).

Global Narcolepsy Drugs Market Trends:

The global market is primarily boosted by the increasing prevalence of narcolepsy. Moreover, rapid advancements in medical research and technology have led to the development of novel therapeutic options and a better understanding of the underlying mechanisms of narcolepsy, which is accelerating the market growth. Apart from this, the growing awareness among healthcare professionals and patients about the available treatment options and the importance of early diagnosis has contributed to the expansion of the market. Additionally, the presence of favorable reimbursement policies and government initiatives to improve the accessibility and affordability of narcolepsy drugs is fueling the market growth. The burgeoning geriatric population and the expanding pharmaceutical industry are also driving the market growth. In line with this, key players are investing in research and development (R&D) activities to introduce new and effective product variants, which is significantly impacting the market growth. The rising demand for personalized medicine and the development of tailored treatment approaches for narcolepsy are acting as other growth-inducing factors. Furthermore, the growing number of clinical trials and drug approvals for narcolepsy drugs, the rapid expansion of online platforms and e-commerce channels for drug distribution and sales, and strategic collaborations, partnerships, and mergers and acquisitions among pharmaceutical companies are propelling the market growth. Looking forward, the market value is projected to reach US$ 6.2 Billion by 2032, expanding at a CAGR of 6.99% during 2024-2032.

Market Summary: 

  • By the type, the market is segregated into narcolepsy with cataplexy, narcolepsy without cataplexy, and secondary narcolepsy.
  • Based on the disease type, the market is divided into daytime extreme sleepiness, cataplexia, and others.
  • By the therapeutic type, the market is segmented into sodium oxybate, central nervous system stimulants, tricyclic antidepressants, selective serotonin reuptake inhibitor, and others.
  • On the basis of the region, the market has been categorized into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa. 
  • The competitive landscape of the industry has also been examined with some of the key players being Avadel Pharmaceuticals plc, Axsome Therapeutics Inc., Bioprojet Pharma, Graymark Healthcare Inc., Jazz Pharmaceuticals plc, Ligand Pharmaceuticals Incorporated, Novartis AG, SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.

Report Scope:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Type, Disease Type, Therapeutic Type, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Avadel Pharmaceuticals plc, Axsome Therapeutics Inc., Bioprojet Pharma, Graymark Healthcare Inc., Jazz Pharmaceuticals plc, Ligand Pharmaceuticals Incorporated, Novartis AG, SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Narcolepsy Drugs Market to Reach US$ 6.2 Billion by 2032, Accelerated by Increasing Prevalence of Narcolepsy
Purchase options

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us

Phone: +1-631-791-1145


Phone: +91-120-433-0800


Phone: +44-753-714-6104


Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More